Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2018 Feb 23;8:3575. doi: 10.1038/s41598-018-21983-w

Investigation of the prevalence of Cognitive Impairment and its risk factors within the elderly population in Shanghai, China

Longbing Ren 1,2,#, Yongtao Zheng 1,2,#, Lezhou Wu 3, Yijun Gu 1,2, Yusheng He 4, Bo Jiang 1,2, Jie Zhang 1,2, Lijuan Zhang 1,2,, Jue Li 1,2,
PMCID: PMC5824836  PMID: 29476112

Abstract

To investigate the prevalence of cognitive impairment and its risk factors among Chinese elders aged over 80 years, a community-based, cross-sectional study was conducted from May to June 2016 in Shanghai, China. Cognitive function was measured by using Mini-Mental Status Examination. Multiple logistic regression assessed associations between risk factors and cognitive impairment. Of 480 participants, 30% were diagnosed with cognitive impairment. Women [adjusted odds ratio (AOR): 1.71, 95% confidence interval (CI): 1.03–2.83], solitary life (AOR: 3.15, 1.89–5.26), monthly income less than 2000 Chinese yuan (AOR: 3.47, 1.18–10.23) were significantly associated with increased risk of cognitive impairment, compared with men, non-solitary life, and monthly income greater than 4000 Chinese yuan, respectively. Overweight (AOR: 0.59, 0.36–0.97), being physically active at least 60 minutes per day (AOR: 0.59, 0.35–0.95), antihypertensive drugs users (AOR: 0.45, 0.28–0.72), and lipid lowering drugs users (AOR: 0.21, 0.06–0.76) significantly lowered the risk of cognitive impairment, compared with normal weight, inadequate outdoor activity, and non-medication users, respectively. Accordingly, this study found that women, solitary life, lower income was associated with increased risk of cognitive impairment, while overweight, being physically active, and antihypertensive and lipid lowering drugs usage might lower the risk.

Introduction

The elderly population such as those aged 80 years and over comprise the fastest growing segment of the global population1. They are more susceptible to most diseases than younger adults and therefore were the leading consumers of healthcare services2. Currently, how to prevent diseases related to aging is one of the greatest challenges in the healthcare field.

Cognitive impairment is one of the most common health problems for elders. It is estimated that the prevalence of cognitive impairment was higher than 40% among elders aged 80 years and over3,4. Cognitive impairment includes mild cognitive impairment and various types of dementia, and is associated with an increasing risk of disability and death5. Due to an unprecedented increase in life expectancy, the global prevalence of cognitive impairment is expected to grow exponentially in the coming years. Cognitive impairment not only causes a significant decline in the quality of life for patients, but also was a substantial economic burden for patients’ families and society in general. In Mainland China, the annual healthcare cost of cognitive impairment is estimated to be at least 9 billion U.S. dollars, while approximately 35 million individuals including patients and their families are either directly or indirectly affected by the deleterious effects of cognitive impairment6. Moreover, there is very few home-based assistance for patients with cognitive impairment in China; only 2% of affected families were able to directly take care of patients6. Accordingly, cognitive impairment is a crucial public health issue in China and effective preventive strategies are needed.

A key part of preventive strategies for cognitive impairment is to identify intervenable risk factors. It has been demonstrated that aging, family history of cognitive impairment, low levels of physical activity, less education, and the presence of epsilon 4 allele of the apolipoprotein E (APOE ε4) gene are major risk factors of cognitive impairment7. In addition, recent studies revealed a mechanism linking the occurrence of cognitive impairment to β-amyloid deposition, which might lead to gray matter atrophy and memory impairment8,9. While population health studies have investigated risk factors for cognitive impairment, however, this is still understudied in the Chinese population. Also, early research in cognitive impairment primarily studied elders aged between 65 and 80 years10,11, and a few even excluded those aged over 80 years12. But lately, as the highest-risk population for cognitive impairment and the fastest-growing population segment, the elderly population aged 80 years and over was increasingly suggested to be studied as an independent population13. Therefore, evidence from previous studies is still less conclusive regarding risk factors of cognitive impairment among Chinese elders aged 80 years and overs.

We conducted a cross-sectional study in a Chinese community-dwelling elderly population. This study aimed to (1) estimate the prevalence of cognitive impairment and potential risk factors among Chinese elders aged over 80 years, and (2) assess whether these risk factors independently predicted the risk of cognitive impairment.

Methods

Study population

A cross-sectional study was conducted from May to June 2016 in Shanghai, China. The target population of this study were those who were at least 80 years old, locally resided in Shanghai, and had normal hearing, vision and speech. Exclusion criteria included: (1) absence of cognitive function or in a vegetative state; (2) diagnoses of schizophrenia or serious mental retardation; (3) residence outside Shanghai. Potential participants were informed by telephone using primary care registration information or notified by community bulletin board. A total of 480 eligible elderly individuals were enrolled in this study, and underwent face-to-face interview and cognitive assessment. The study was approved by medical ethical review committee of Tongji University and informed consent was obtained for all participants. We confirm that all methods were performed in accordance with the relevant guidelines and regulations.

Sociodemographic and Health-related Data

An interviewer-administered questionnaire was used to collect sociodemographic and health-related data including gender, age, education, marriage, personal income, smoking and drinking habits, and physical activities. Self-reported medical conditions were recorded including hypertension, diabetes, dyslipidemia, coronary heart disease, chronic obstructive pulmonary disease, tumor, and chronic kidney disease. Medication history was also self-reported including antidiabetic, antihypertensive, anticoagulation, diuretic, and lipid lowering drugs. Education attainment was summarized as elementary school or less (≤6 years education), middle school (6–9 years education), and at least some high school (>9 years of education). Marital status was measured with four response categories including married or cohabitating, never married, widowed, and divorced or separated; marital status was further dichotomized as solitary vs. non-solitary life. Personal income was categorized into ≤2000, 2000 to 4000, and >4000 Chinese Yuan per month. Physical activity was dichotomized as <60 minutes vs. ≥60 minutes outdoor activity per day (e.g., walk, shopping and so on). Weight and height was measured and Body Mass Index (BMI) was calculated as weight in kilograms divided by height in meters squared (kg/m2); BMI <24 and ≥24 kg/m2 were categorized as normal and overweight, respectively.

Assessment of Cognitive Function

Cognitive function was assessed using Chinese versions of the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) in the pilot study. Both instruments have been shown valid and reliable among Chinese who are culturally and linguistically different from westerners14,15. The assessments were conducted strictly following the guidelines and protocols from the instrument advisory committees16,17.

The MMSE is a 30-point questionnaire measuring five cognitive domains including orientation (e.g., orientation to time and place), registration (e.g., repeating named prompts), language and praxis, attention and calculation, and recall. The raw total score need to be adjusted for education attainments when diagnosing severity of cognitive impairment14.

The MoCA is another 30-point questionnaire assessing eight areas of cognitive function including attention, concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation. A total score of 26 points or higher indicates normal cognition18.

Our pilot study indicated a high proportion of low-educated participants (this was also later confirmed by the formal study: only 10% participants received some high school education while 64% participants only attended elementary school or even less). Accordingly, the MMSE was finally used as a measurement of cognitive function in the formal study, since the MMSE is able to assess cognitive function after factoring in individual educational level whereas the MoCA has the limitation of education bias if the raw score cannot be appropriately adjusted19. A total MMSE score less than 20 and 24 was therefore used to diagnose cognitive impairment, respectively for participants with only elementary school education and those having more than elementary school. The application of these two cut-off values has been well-documented among Chinese populations regarding acceptable sensitivity and specificity14,15,20,21.

Quality Control

All investigators received standard training by neurologists and psychiatrists before data collection. Face-to-face interview and cognitive assessment (the MMSE and MoCA) were both performed on the same day.

Reliability of the MMSE

The test-retest reliability of the MMSE was assessed in a random subsample (n = 30, 18 men and 12 women, age range 80–92 years, average age 85.1 years). The retest was completed in 6 months after the initial one. The test and retest MMSE scores were highly correlated (r = 0.840, p < 0.001). A paired t-test indicated no significant difference in MMSE scores between two tests (mean ± standard deviation, 23.33 ± 4.44 vs. 22.50 ± 5.14, p > 0.05). Other two reliability statistics were also calculated: coincidence rate equaled 90% and Kappa coefficient was 0.667 (p < 0.001). All evaluation above indicated substantial agreement between repeated MMSE.

In addition, a Bland-Altman plot was used to illustrate the MMSE reliability. The differences of two repeated measurements were plotted against means of repeated measurements. Two horizontal dotted lines then were added indicating 95% limits of agreement, which were correspondingly estimated by mean difference ±1.96 times the standard deviation of the differences (mean difference was expected to be zero). As shown in Fig. 1, approximately 90% of differences between repeated MMSE fell within the interval provided by 95% limits of agreement. Therefore, reliability of the MMSE was demonstrated.

Figure 1.

Figure 1

The Bland-Altman plot for the MMSE reliability assessment. The graph displays a scatter diagram of the test-retest differences plotted against the averages of the two tests. Horizontal dotted lines were drawn at the limits of agreement, which were defined as the mean difference ±1.96 times the standard deviation of the differences. For repeated measurements, the expected mean difference was set to zero.

Statistical analyses

EpiData 3.1 (Odense, Denmark) was used for data input, and statistical software SPSS 20.0 (SPSS Inc., Chicago, IL, USA) was used for data management and analyses. The chi-squared test was used to analyze the crude differences between participants with cognitive impairment versus those with normal cognition. Multiple logistic regression analysis was applied to assess independent risk factors associated with increased risk of cognitive impairment; multivariable-adjusted odds ratio (AOR) and 95% confidence interval (CI) was calculated for each risk factor indicating the magnitude of cognitive impairment risk. Multiple correspondence analysis (MCA) was further conducted to present the association of potential risk factors with cognitive impairment. To further assess the domain-specific cognitive function, bar plots were produced presenting the differences in average domain-specific MMSE scores by gender and by cognitive impairment diagnosis. (For direct comparison, five domain-specific MMSE scores were transformed to a 0–100% scale: sum of the points earned divided by the total points possible.) Two-sided p value less than 0.05 was considered statistically significant.

Results

Demographic and health characteristics of study participants by cognitive function status were summarized in Table 1. Of 480 participants, 29.9% were diagnosed with cognitive impairment. The majority of participants were female (55.3%), aged from 80 to 85 years (63.6%), solitary (51.6%), attended only elementary school or even less (64%), had a monthly income of between 2000 and 4000 Chinese yuan (54.8%), never smoked (80.4%), never drank (88.9%), had outdoor activity more than 60 minutes per day (50.8%), and had a normal BMI less than 24 (55.4%). The three most prevalent self-reported diseases were hypertension (57.2%), coronary heart disease (24.5%), and diabetes (16.4%). The three most commonly taken medications were antihypertensive (55.2%), anticoagulation (21.3%), and antidiabetic (14.4%) drugs. When comparing participants with cognitive impairment to those with normal cognitive function, there were significant crude differences in gender, marital status, personal income, physical activity, hypertension, antihypertensive usage, and lipid lowering drugs usage (all p < 0.05).

Table 1.

Demographic and health characteristics of participants with cognitive impairment vs. normal cognition.

Risk factors Cognitive Impairment (n = 144) Normal Cognition (n = 336) p-value
Sociodemographic and behavioral features
Gender <0.001
  Men 41(28.5%) 174(51.8%)
  Women 103(71.5%) 162(48.2%)
Age (year) 0.094
  ≤85 82(56.9%) 223(66.4%)
  ≥86 59(43.1%) 112(33.6%)
Education
 Elementary school or less 106(73.6%) 200(59.5%) 0.001
  Middle school 33(22.9%) 91(27.1%)
 At least some high school 5(3.5%) 45(13.5%)
Marital Status <0.001
  Solitary 107(74.3%) 141(42.0%)
  Non-solitary 37(25.7%) 195(58.0%)
Monthly income (Chinese yuan) 0.001
  ≤2000 53(37.9%) 85(27.6%)
  2000–4000 82(58.6%) 181(58.8%)
  >4000 5(3.5%) 42(13.6%)
Body Mass Index (kg/m2) 0.002
  Normal (BMI <24) 93(64.6%) 173(51.5%)
 Overweight (BMI ≥24) 41(35.4%) 151(48.5%)
Smoking 0.334
  Never smoker 122(84.7%) 264(78.6%)
  Ever smoker 14(9.7%) 49(14.6%)
  Current smoker 8(5.6%) 23(6.8%)
Drinking 0.161
  Never drinker 134(93.1%) 293(87.2%)
  Ever drinker 7(4.9%) 27(8.0%)
  Current drinker 3(2.0%) 16(4.8%)
Physical activity 0.006
  <60 min per day 85(59.0%) 151(44.9%)
  ≥60 min per day 59(41.0%) 185(55.1%)
Medical history
  Hypertension 70(48.6%) 205(61.0%) 0.016
  Diabetes 26(18.1%) 53(15.8%) 0.502
  Dyslipidemia 13(9.0%) 49(14.6%) 0.135
 Coronary heart disease 28(19.4%) 90(26.8%) 0.105
 Chronic obstructive pulmonary disease 8(5.6%) 11(3.6%) 0.306
  Tumor 2(1.4%) 12(3.6%) 0.314
 Chronic kidney disease 2(1.4%) 11(3.3%) 0.314
  Other diseases 13(7.1%) 16(4.8%) 0.246
Medications
  Antidiabetic 23(16.0%) 46(13.7%) 0.514
  Antihypertensive 60(41.7%) 205(61.0%) <0.001
 Lipid lowering drugs 3(2.1%) 32(9.5%) 0.004
  Anticoagulation 24(16.7%) 78(23.5%) 0.105
  Diuretics 5(4.2%) 17(5.1%) 0.491

Categorical variables were presented as count and column percent.

The adjusted associations between risk factors and the risk of cognitive impairment were shown in Table 2. Gender, marital status, personal income, BMI, physical activity, antihypertensive usage, and lipid lowering drugs usage were found to be independent predictors for cognitive impairment risk (all p < 0.05). After controlling for confounding, women were more likely than men to have cognitive impairment (AOR: 1.71, 95% CI: 1.03–2.83); solitary life (AOR: 3.15, 95% CI: 1.89–5.26) and monthly income less than 2000 Chinese yuan (AOR: 3.47, 95% CI: 1.18–10.23) was significantly associated with increased risk of cognitive impairment, compared with non-solitary life and monthly income greater than 4000 Chinese yuan, respectively. In contrast, being overweight (AOR: 0.59, 95% CI: 0.36–0.97) and physically active at least 60 minutes per day (AOR: 0.59, 95% CI: 0.35–0.95) was both significantly associated with a more than 40% decrease in cognitive impairment risk, compared with normal weight and inadequate outdoor activity (less than 60 minutes per day), respectively. Also, antihypertensive (AOR: 0.45, 95% CI: 0.28–0.72) and lipid lowering drugs (AOR: 0.21, 95% CI: 0.06–0.76) usage lowered cognitive impairment risk. Age was not associated with cognitive impairment risk in this elderly Chinese population (AOR: 0.81, 95% CI: 0.49–1.34).

Table 2.

Adjusted odds ratio for the risk of cognitive impairment.

Predictors AOR 95% CI p-value
Gender (women) 1.707 1.028–2.833 0.039
Age (≥86 years) 0.813 0.492–1.341 0.417
Marital status (solitary life) 3.152 1.889–5.261 0.000
Monthly income
≤2000 Chinese yuan 3.472 1.178–10.231 0.024
2000–4000 Chinese yuan 1.721 1.031–2.875 0.038
BMI (overweight, BMI ≥24 kg/m2) 0.590 0.359–0.969 0.037
Physical activity (≥60 min per day) 0.580 0.354–0.951 0.031
Antihypertensive drugs use 0.447 0.277–0.721 0.001
Lipid lowering drugs use 0.212 0.059–0.764 0.018

Multiple logistic regression analysis estimated the risk of cognitive impairment associated with potentially independent risk factors. The reference groups for comparison were men, age ≤85 years, non-solitary life, monthly income >4000 Chinese yuan, BMI <24, physical activity <60 minutes per day, no use of antihypertensive drugs, and no use of lipid lowering drugs, respectively.

The associations between risk factors and cognitive impairment were further presented using the MCA plot (Fig. 2). In the MCA plot, the associations are interpreted based on the distance between two variables in the same quadrant: when two variables appear in the similar direction from centroid, the closer distance suggested a more likely association22. As shown in Fig. 2, gender, BMI, antihypertensive and lipid lowering drugs were more likely to be associated with cognitive function in this Chinese elderly population. In contrast, age, marriage, monthly income, and daily physical activity were less likely to predict cognitive function. The MCA plot is a statistically descriptive technique and was applied as a supplement for regression analysis in this study.

Figure 2.

Figure 2

Multiple correspondence analysis (MCA) plot. Risk factors were presented as icons and a brief description was labeled near the icon indicating a specific category of risk factors. To interpret MCA plot, icons closed together in the same quadrants along the similar direction from centroid would be indicative of possible associations. BMI, body mass index; PA, physical activity; AHD, antihypertensive drugs; LLD, lipid lowering drugs.

Transformed domain-specific MMSE scores stratified by gender and the diagnosis of cognitive impairment were presented in Fig. 3. In this elderly Chinese population, MMSE scores appeared to be obviously lowest in the cognitive domains of attention and calculation (49.3%), as well as recall (39.7%). This disparity remained when assessing women and men separately. Moreover, domain-specific MMSE scores were consistently lower among elders with cognitive impairment than among those with normal cognition; however, the differences in MMES scores were remarkably large in the attention and calculation domain (66.5% vs. 9.0%), as well as recall domain (52.7% vs. 9.3%).

Figure 3.

Figure 3

Domain-specific cognitive function by gender and diagnosis of cognitive impairment. Five domain-specific MMSE scores were transformed to a 0–100% scale (sum of the points earned divided by the total points possible). The scoring averages were plotted.

Discussion

Cognitive impairment is an aging-related disease, which can result in various health problems, including disability and death. It has been reported that the prevalence of cognitive impairment is greater than 40% among elderly individuals3. Cognitive impairment is not only highly prevalent, but has a great impact on life quality, thus imposing a substantial socioeconomic burden. Cognitive impairment is now a major public health concern in Mainland China23, and to identify potential risk factors of cognitive impairment is fundamental for developing preventive strategies.

We conducted a community-based, cross-sectional study to assess independent predictors for the risk of cognitive impairment. Our findings showed that approximately 30% of participants aged 80 years and over were diagnosed with cognitive impairment, with a prevalence of 19% among men and 39% among women. Women were further found to be associated with increased risk of cognitive impairment after controlling for confounding. This is consistent with a previous study wherein male patients with Alzheimer’s disease outperformed female counterparts in cognitive function24. A possible explanation for this female disadvantage was hormonal influence: the decrease in estrogen level associated with aging may adversely affect cognitive function among women24.

Another independent risk factor for cognitive impairment was marital status: solitary elders had a threefold higher risk of cognitive impairment than those having a non-solitary life. Solitary individuals often have less opportunity to communicate and are less involved in social activities, and thus lower social engagements may result in higher risk of cognitive impairment25.

Lower personal income was also found predictive of increased risk of cognitive impairment. There are several explanations for this relationship: (1) lower income is associated worse nutritional intake, such as less consumption of dairy products26; (2) lower socioeconomic status is associated less access to healthcare services2,27; (3) lower socioeconomic status is also associated with less social activity and less interpersonal communication, and lack of income can even lead to social isolation25,28.

Other factors appeared to reduce the risk of cognitive impairment including overweight, being physically active, and antihypertensive and lipid lowering drugs usage. Overweight (BMI >24 kg/m2) was associated with a 40% reduction in cognitive impairment risk compared with normal weight, which was consistent with a previous study in a Finnish population29. Higher BMI reflects increased body fat30,31. Body fat such as leg fat has been demonstrated to improve glucose metabolism32, and better cerebral glucose metabolism might lower the risk of cognitive impairment33. In addition, since cognitive function is closely correlated to nutrition34, low body fat among elders might impair cognitive function via malnutrition35,36.

Increased daily physical activity was found associated with reduced risk of cognitive impairment independent of other confounders. The benefits of being physically active for cognitive impairment among elders has been widely studied37. Randomized controlled trials even assessed exercise-based interventions, indicating physical activities effectively lower the risk of dementia and improve multiple aspects of cognitive function38. Our analysis further confirmed this finding among individuals aged over 80 years, and suggested the oldest population can still significantly benefit from daily physical activity for their cognitive function.

We also found antihypertensive and lipid lowering drugs usage were independent protective factors for cognitive function. Population health studies inconsistently reported the relationships between serum cholesterol level and cognitive function among elders39,40. A recent study indicated a decreased risk of cognitive impairment associated with higher serum cholesterol levels39; in contrast, earlier research found significantly higher cholesterol levels among elderly individuals with cognitive impairment, and suggested cholesterol lowering therapy such as lipid lowering drugs might prevent cognitive impairment beyond its cardiovascular benefit41,42. Our findings now confirmed that lipid lowering drugs usage might lower the risk of cognitive impairment among Chinese elders aged over 80 years. Evidences for possible biological mechanisms also linked high cholesterol level to neurodegenerative diseases43: abnormal cholesterol metabolism increased the production and deposition of β-amyloid in the brain, and in turn lead to cognitive impairment8,9; cholesterol-carrying proteins also markedly increase the risk of cognitive impairment43. Despite such evidence, randomized clinical trials are still needed to clarify these inconsistent findings.

The present study demonstrated the protective effect by antihypertensive drugs for cognitive impairment. This confirmed previous findings: antihypertensive treatment was found a 50% reduction in dementia incidence in an elderly population44; among hypertensive patients, those having antihypertensive treatment had significantly better cognitive performance than untreated counterparts45; poorer blood pressure control was associated with higher risk of cognitive impairment among patients who have been treated for hypertension46. These benefits can be explained by the fact that antihypertensive drugs prevent or slow brain white matter lesions caused by high blood pressure.

Additionally, previous studies have reported that smoking, alcohol abuse, diabetes, and hyperlipidemia might be risk factors of cognitive impairment in all age groups, and especially for those aged 65 years and over21,4749. However, none of these were identified in this elderly Chinese population aged over 80 years. This may be due to so called competing causes of death. Of 480 study participants, 81% have never smoked and 90% have never drunk, while only 16% were diabetic and 13% had dyslipidemia. It suggests elders with these risk factors might pass away before reaching the age 80 years.

There are limitations to this study that should be noted. First, a cross-sectional study may not fully assess the temporality between risk factors and cognitive outcome, and thus the causal relationship is still indeterminate. A longitudinal follow-up study is needed to address the limitation. Second, the sample size of this study may not provide adequate statistical power to detect significant difference, especially for categorical variables with rare events. Third, this study utilized the MMSE rather than gold standard measures50 (e.g., DSM-111, NINCDS-ADRDA, and clinical record) to evaluate cognitive function, and thus we were unable to diagnose dementia. Also, there might be more measurement bias comparing the MMSE with gold standard measures, but the reliability and validity of the MMSE have been well assessed among different populations including elderly Chinese14,15,20,21,51. Finally, blood samples were not collected in this study and therefore laboratory indicators such as blood glucose and lipid could not be measured. Self-reported medical conditions were less valid than that diagnosed using laboratory measures. This may also result in possible residual confounding when assessing adjusted association between risk factors and cognitive impairment.

Conclusion

Approximately 30% of Chinese elders aged 80 years and over were diagnosed with cognitive impairment. The risk of cognitive impairment was independently associated with risk factors such as gender, marital status, personal income, BMI, physical activity, and antihypertensive and lipid lowering drugs usage: women, solitary life, lower income was associated with increased risk of cognitive impairment, while overweight, being physically active, and antihypertensive and lipid lowering drugs usage was associated with lower risk of cognitive impairment. Among five specific cognitive functions, the domain of attention and calculation and recall domain were markedly weak for elders with cognitive impairment.

Acknowledgements

This work was supported by Shanghai Key Laboratory of Meteorology and Health (Grant No: QXJK201503), “Twelfth five-year” national support program “disaster relief and emergency rescue key technologies in rural regional” (Grant No: 2014BAL05B06), and Shanghai Municipal Commission of Health and Family Planning Project (Grant No: 201440312) to Dr. Lijuan Zhang. Effects of adrenergic receptor SNPs (Single Nucleotide Polymorphisms) and PWV (Pulse Wave Velocity), CBP (Complete Blood Picture) on incidence and drug susceptibility of heart failure with preserved ejection fraction (Grant No: 81471402) and the study of mechanisms of cardiac arrhythmia occurrence and intervention the National Key Basic Research Program of China (Grant No: 2013CB531100) to Jue Li.

Author Contributions

Jue Li and Lijuan Zhang designed the research; Longbing Ren, Yongtao Zheng and Lijuan Zhang conducted the data analyses; Longbing Ren, Yongtao Zheng, and Lijuan Zhang wrote the draft of initial manuscript; Lezhou Wu critically contributed to data reanalysis and draft revision; Yijun Gu, Yusheng He, Bo Jiang, Jie Zhang contributed to the interpretation of the data and preparation of the manuscript.

Competing Interests

The authors declare no competing interests.

Footnotes

Longbing Ren and Yongtao Zheng contributed equally to this work.

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Lijuan Zhang, Email: zhangxiaoyi@tongji.edu.cn.

Jue Li, Email: jueli@tongji.edu.cn.

References

  • 1.Duke C. The Frail Elderly Community-Based Case Management Project. Geriatric nursing. 2005;26:122–127. doi: 10.1016/j.gerinurse.2005.03.003. [DOI] [PubMed] [Google Scholar]
  • 2.Kelley AS, McGarry K, Gorges R, Skinner JS. The burden of health care costs for patients with dementia in the last 5 years of life. Annals of internal medicine. 2015;163:729–736. doi: 10.7326/M15-0381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Yaffe K, et al. Mild cognitive impairment, dementia, and their subtypes in oldest old women. Archives of neurology. 2011;68:631–636. doi: 10.1001/archneurol.2011.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hebert. LE, et al. Age-Specific Incidence of Alzheimer’s Disease in a Community Population. Jama. 1995;273:1354–1359. doi: 10.1001/jama.1995.03520410048025. [DOI] [PubMed] [Google Scholar]
  • 5.Formiga F, et al. Predictors of cognitive decline in 85-year-old patients without cognitive impairment at baseline: 2-year follow-up of the octabaix study. American journal of Alzheimer’s disease and other dementias. 2013;28:147–153. doi: 10.1177/1533317512475021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Su X, et al. Prevalence and predictors of mild cognitive impairment in Xi’an: a community-based study among the elders. PloS one. 2014;9:e83217. doi: 10.1371/journal.pone.0083217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wallin K, Bostrom G, Kivipelto M, Gustafson Y. Risk factors for incident dementia in the very old. International psychogeriatrics. 2013;25:1135–1143. doi: 10.1017/S1041610213000409. [DOI] [PubMed] [Google Scholar]
  • 8.Dore V, et al. Cross-sectional and longitudinal analysis of the relationship between Abeta deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease. JAMA neurology. 2013;70:903–911. doi: 10.1001/jamaneurol.2013.1062. [DOI] [PubMed] [Google Scholar]
  • 9.Lo Coco D, Lopez G, Corrao S. Cognitive impairment and stroke in elderly patients. Vascular health and risk management. 2016;12:105–116. doi: 10.2147/VHRM.S75306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Klich-Raczka A, et al. The assessment of cognitive impairment suspected of dementia in Polish elderly people: results of the population-based PolSenior Study. Experimental gerontology. 2014;57:233–242. doi: 10.1016/j.exger.2014.06.003. [DOI] [PubMed] [Google Scholar]
  • 11.Lawrence, B. J., Gasson, N. & Loftus, A. M. Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson’s Disease. Scientific reports6, (2016). [DOI] [PMC free article] [PubMed]
  • 12.Chen JC, et al. Sleep duration, cognitive decline, anddementia risk in older women. Alzheimer’s & dementia: the journal of the Alzheimer’s Association. 2015;12:21–33. doi: 10.1016/j.jalz.2015.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Rodriguez-Fernandez, J. M., Danies, E., Martinez-Ortega, J. & Chen, W. C. Cognitive decline, body mass index, and waist circumference in community-dwelling elderly participants. Journal of geriatric psychiatry and neurology, 891988716686832 (2017). [DOI] [PubMed]
  • 14.Arevalo-Rodriguez, I. et al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment (MCI). The Cochrane database of systematic reviews, CD010783 (2015). [DOI] [PMC free article] [PubMed]
  • 15.Tan JP, et al. Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population. Journal of Alzheimer’s disease: JAD. 2015;43:1403–1412. doi: 10.3233/JAD-141278. [DOI] [PubMed] [Google Scholar]
  • 16.Authority, I. H. P. Standardised Mini-Mental State Examination (SMMSE) - Guidelines for administration and scoring instructions (text version). (2014).
  • 17.MD, Z.N. Montreal Cognitive Assessment (MoCA) Administration and Scoring Instructions (2010).
  • 18.Nasreddine. ZS, et al. The Montreal Cognitive Assessment, MoCA A brief screening tool for Mild Cognitive Impairment. Journal of the American Geriatrics Society. 2005;53:695–699. doi: 10.1111/j.1532-5415.2005.53221.x. [DOI] [PubMed] [Google Scholar]
  • 19.Rambe AS, Fitri FI. Correlation between the Montreal Cognitive Assessment-Indonesian Version (Moca-INA) and the Mini-Mental State Examination (MMSE) in Elderly. Open Access Macedonian Journal of Medical Sciences. 2017;5:915–919. doi: 10.3889/oamjms.2017.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Tombaugh. TN, J. CN, Mclntyre M. The Mini-Mental State Examination:a comprehensive review. Journal of the American Geriatrics Society. 1992;40:922–935. doi: 10.1111/j.1532-5415.1992.tb01992.x. [DOI] [PubMed] [Google Scholar]
  • 21.Luo. L, Yang M, Hao Q, Yue J, Dong B. Cross-sectional study examining the association between metabolic syndrome and cognitive function among the oldest old. Journal of the American Medical Directors Association. 2013;14:105–108. doi: 10.1016/j.jamda.2012.10.001. [DOI] [PubMed] [Google Scholar]
  • 22.Wu L, et al. Association between risk factors and left ventricular remodeling in middle-aged and aged population: a community-based study. Journal of hypertension. 2012;30:1862–1873. doi: 10.1097/HJH.0b013e3283563418. [DOI] [PubMed] [Google Scholar]
  • 23.Yu HM, et al. Multi-state Markov model in outcome of mild cognitive impairments among community elderly residents in Mainland China. International psychogeriatrics. 2013;25:797–804. doi: 10.1017/S1041610212002220. [DOI] [PubMed] [Google Scholar]
  • 24.Laws KR, Irvine K, Gale TM. Sex differences in cognitive impairment in Alzheimer’s disease. World journal of psychiatry. 2016;6:54–65. doi: 10.5498/wjp.v6.i1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Middleton LE, Yaffe K. Promising strategies for the prevention of dementia. Archives of neurology. 2009;66:1210–1215. doi: 10.1001/archneurol.2009.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Tucker KL. Nutrient intake, nutritional status, and cognitive function with aging. Annals of the New York Academy of Sciences. 2016;1367:38–49. doi: 10.1111/nyas.13062. [DOI] [PubMed] [Google Scholar]
  • 27.Ton TG, et al. The financial burden and health care utilization patterns associated with amnestic mild cognitive impairment. Alzheimer’s & dementia: the journal of the Alzheimer’s Association. 2017;13:217–224. doi: 10.1016/j.jalz.2016.08.009. [DOI] [PubMed] [Google Scholar]
  • 28.Rosso AL, et al. Neighborhood Socioeconomic Status and Cognitive Function in Late Life. American journal of epidemiology. 2016;183:1088–1097. doi: 10.1093/aje/kwv337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Dahl AK, Lopponen M, Isoaho R, Berg S, Kivela SL. Overweight and obesity in old age are not associated with greater dementia risk. Journal of the American Geriatrics Society. 2008;56:2261–2266. doi: 10.1111/j.1532-5415.2008.01958.x. [DOI] [PubMed] [Google Scholar]
  • 30.Guallar-Castillon P, et al. BMI, waist circumference, and mortality according to health status in the older adult population of Spain. Obesity. 2009;17:2232–2238. doi: 10.1038/oby.2009.115. [DOI] [PubMed] [Google Scholar]
  • 31.Kuk J, Janiszewski P, Ross R. Body mass index and hip and thigh circumferences are negatively associated with visceral adipose tissue after control for waist circumference. American Journal of Clinical Nutrition. 2007;85:1540–1544. doi: 10.1093/ajcn/85.6.1540. [DOI] [PubMed] [Google Scholar]
  • 32.Snijder M, MStehouwer CV, Heine R, Seidell J. Trunk Fat and Leg Fat Have Independent and Opposite Associations With Fasting and Postload Glucose Levels. Diabetes Care. 2004;27:372–377. doi: 10.2337/diacare.27.2.372. [DOI] [PubMed] [Google Scholar]
  • 33.Firbank MJ, et al. Cerebral glucose metabolism and cognition in newly diagnosed Parkinson’s disease: ICICLE-PD study. Journal of Neurology, Neurosurgery &amp; Psychiatry. 2017;88:310–316. doi: 10.1136/jnnp-2016-313918. [DOI] [PubMed] [Google Scholar]
  • 34.Coin A, et al. Nutritional predictors of cognitive impairment severity in demented elderly patients: The key role of BMI. The Journal of Nutrition, Health and Aging. 2012;16:553–556. doi: 10.1007/s12603-012-0052-x. [DOI] [PubMed] [Google Scholar]
  • 35.Power B, et al. Body Adiposity in Later Life and the Incidence of Dementia: The Health in Men Study. PloS one. 2011;6:e17902. doi: 10.1371/journal.pone.0017902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Nourhashémi F, et al. Body mass index and incidence of dementia:The PAQUID study. Neurology. 2003;60:117–119. doi: 10.1212/01.WNL.0000038910.46217.AA. [DOI] [PubMed] [Google Scholar]
  • 37.Lü J, Fu W, Liu Y. Physical activity and cognitive function among older adults in China: A systematic review. Journal of Sport and Health Science. 2016;5:287–296. doi: 10.1016/j.jshs.2016.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Yang SY, et al. The effects of aerobic exercise on cognitive function of Alzheimer’s disease patients. CNS & Neurological Disorders-Drug Targets. 2015;14:1292–1297. doi: 10.2174/1871527315666151111123319. [DOI] [PubMed] [Google Scholar]
  • 39.LV Y-B, et al. Serum cholesterol levels within the high normal range are associated with better cognitive performance among Chinese Elderly. The journal of nutrition, health & aging. 2016;20:1–8. doi: 10.1007/s12603-016-0701-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Rnnemaa E, Zethelius B, Lannfelt L, Kilander L. Vascular risk factors and dementia 40-Year Follow-Up of a Population-Based Cohort. Dementia and geriatric cognitive disorders. 2011;31:460–466. doi: 10.1159/000330020. [DOI] [PubMed] [Google Scholar]
  • 41.Helzner EP, et al. Contribution of vascular risk factors to the progression in Alzheimer’s disease. Archives of neurology. 2009;66:343–348. doi: 10.1001/archneur.66.3.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Rantanen KK, et al. Cholesterol in midlife increases the risk of Alzheimer’s disease during an up to 43-year follow-up. European Geriatric Medicine. 2014;5:390–393. doi: 10.1016/j.eurger.2014.05.002. [DOI] [Google Scholar]
  • 43.Vance JE. Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases. Disease models & mechanisms. 2012;5:746–755. doi: 10.1242/dmm.010124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Forette F, et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Archives of Internal Medicine. 2002;162:2046–2052. doi: 10.1001/archinte.162.18.2046. [DOI] [PubMed] [Google Scholar]
  • 45.Tzourio C, Dufouil C, Ducimetie’re P, Alpe´rovitch A. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology. 1999;53:1948–1952. doi: 10.1212/WNL.53.9.1948. [DOI] [PubMed] [Google Scholar]
  • 46.Spinelli C, et al. Impaired cognitive executive dysfunction in adult treated hypertensives with a confirmed diagnosis of poorly controlled blood pressure. International Journal of Medical Sciences. 2014;11:771–778. doi: 10.7150/ijms.8147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Hoang TD, Byers AL, Barnes DE, Yaffe K. Alcohol consumption patterns and cognitive impairment in older women. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry. 2014;22:1663–1667. doi: 10.1016/j.jagp.2014.04.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Chei CL, et al. Vitamin D levels and cognition in elderly adults in China. Journal of the American Geriatrics Society. 2014;62:2125–2129. doi: 10.1111/jgs.13082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Zou C, et al. Predictors of 49-month mortality in Chinese nonagenarians and centenarians in PLAD study. Aging clinical and experimental research. 2015;27:821–827. doi: 10.1007/s40520-015-0355-y. [DOI] [PubMed] [Google Scholar]
  • 50.McKhann G, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology. 1984;34:939–944. doi: 10.1212/WNL.34.7.939. [DOI] [PubMed] [Google Scholar]
  • 51.Jagielski AC, et al. Glycaemia is associated with cognitive impairment in older adults: the Guangzhou Biobank Cohort Study. Age and ageing. 2015;44:65–71. doi: 10.1093/ageing/afu088. [DOI] [PubMed] [Google Scholar]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES